Superinvestor Tracker
← All Investors

HALOZYME THERAPEUTICS INC

HALO 0.25 03-01-27

Holders

2

Combined Value

$28M

Combined Shares

26,955,000

Investor Activity

$0.76$0.98$1.20$1.43Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26▲1▲1 ▼1▲4▲1 ▼3▲2 ▼1▼1
BUYSELLImplied priceClick a quarter to see who traded

Held By

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of
Ken Griffin - Citadel Advisors$20M0.00%~$1.08—Sold Q1 2026Q1 2026
Steve Cohen - Point72$7.8M0.01%~$1.02—Bought Q4 2025Q1 2026

Recent Activity

QuarterInvestorActionEst. ValueEst. Price
Q1 2026Ken Griffin - Citadel AdvisorsSELL−$23M~$1.04
Q4 2025Israel Englander - Millennium ManagementSOLD OUT−$67M~$1.15
Q4 2025Ken Griffin - Citadel AdvisorsNEW BUY+$45M~$1.08
Q4 2025Steve Cohen - Point72BUY+$2.7M~$1.08
Q3 2025Steve Cohen - Point72SELL−$74M~$1.15
Q3 2025Israel Englander - Millennium ManagementBUY+$39M~$1.15
Q3 2025Ken Griffin - Citadel AdvisorsSOLD OUT−$24M~$1.00
Q3 2025Howard Marks - Oaktree CapitalSOLD OUT−$2.0M~$1.00
Q2 2025Steve Cohen - Point72NEW BUY+$69M~$0.99
Q2 2025Israel Englander - Millennium ManagementNEW BUY+$24M~$1.00
Q2 2025Ken Griffin - Citadel AdvisorsBUY+$19M~$1.00
Q2 2025Howard Marks - Oaktree CapitalNEW BUY+$2.0M~$1.00
Q1 2025Steve Cohen - Point72SOLD OUT−$10M~$0.96
Q1 2025Ken Griffin - Citadel AdvisorsNEW BUY+$5.3M~$1.06
Q4 2024Steve Cohen - Point72NEW BUY+$10M~$0.96

Ownership History

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q1 2026226,955,000−45.7%$28M$1.04
Q4 2025249,657,000−22.6%$53M$1.08
Q3 2025264,128,000−47.4%$73M$1.15
Q2 20254122,000,000+2340.0%$121M$1.00
Q1 202515,000,000−54.5%$5.3M$1.06
Q4 2024111,000,000—$10M$0.96